Experienced in Ewing Sarcoma

Dr. David J. Sher

Radiation Oncology
University Of Texas Southwestern Medical Center At Dallas
5201 Harry Hines Blvd, 
Dallas, TX 
 (553.0 mi)
Clinical Trials:Currently Recruiting for 3 Trials
Accepting New Patients
Offers Telehealth
Experienced in Ewing Sarcoma
University Of Texas Southwestern Medical Center At Dallas
5201 Harry Hines Blvd, 
Dallas, TX 
 (553.0 mi)
OverviewInsuranceLocationsClinical Research

Overview

David Sher is a Radiation Oncologist in Dallas, Texas. Dr. Sher and is rated as an Experienced provider by MediFind in the treatment of Ewing Sarcoma. His top areas of expertise are Throat Cancer, Laryngeal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Sinus Cancer, and Gastrostomy. Dr. Sher is currently accepting new patients.

His clinical research consists of co-authoring 192 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Radiation Oncology
Licenses
Radiology in MA
Hospital Affiliations
UT Of Texas Southwestern University Hospital - William P. Clements Jr.
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Humana

Locations

UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER AT DALLAS
5201 Harry Hines Blvd, Dallas, TX 75235
Other Locations
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER AT DALLAS
6201 Harry Hines Blvd, Dermatology, Dallas, TX 75390

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Randomized Phase II/III Trial of Adjuvant Radiation Therapy With Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
Randomized Phase II/III Trial of Adjuvant Radiation Therapy With Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
Enrollment Status: Recruiting
Publish Date: February 26, 2025
Intervention Type: Other, Procedure, Drug, Radiation, Biological
Study Drugs: Atezolizumab, Cetuximab, Cisplatin, Docetaxel
Study Phase: Phase 2/Phase 3
Phase II Randomized Trial of Radiotherapy With or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) With TP53 Sequencing
Phase II Randomized Trial of Radiotherapy With or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) With TP53 Sequencing
Enrollment Status: Recruiting
Publish Date: August 09, 2024
Intervention Type: Drug, Other, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
KEYSTROKE: A Randomized Phase II Study of Pembrolizumab (KEYTRUDA®) Plus Stereotactic Re-irradiation Versus SBRT Alone for Locoregionally Recurrent or Second Primary Head and Neck Carcinoma
KEYSTROKE: A Randomized Phase II Study of Pembrolizumab (KEYTRUDA®) Plus Stereotactic Re-irradiation Versus SBRT Alone for Locoregionally Recurrent or Second Primary Head and Neck Carcinoma
Enrollment Status: Recruiting
Publish Date: June 02, 2023
Intervention Type: Radiation, Drug
Study Drug: Pembrolizumab
Study Phase: Phase 2
A Phase III Randomized Study of Maintenance Nivolumab Versus Observation in Patients With Locally Advanced, Intermediate Risk HPV Positive OPSCC
A Phase III Randomized Study of Maintenance Nivolumab Versus Observation in Patients With Locally Advanced, Intermediate Risk HPV Positive OPSCC
Enrollment Status: Suspended
Publish Date: February 25, 2025
Intervention Type: Procedure, Drug, Biological, Radiation, Other
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 3
A Randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
A Randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
Enrollment Status: Active_not_recruiting
Publish Date: February 13, 2025
Intervention Type: Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
Enrollment Status: Active_not_recruiting
Publish Date: November 06, 2024
Intervention Type: Other, Drug, Radiation
Study Drugs: Cisplatin, Fluorouracil, Gemcitabine Hydrochloride, Paclitaxel
Study Phase: Phase 2/Phase 3
A Phase 2a Randomized, Parallel Group, Open Label, Multicenter Study to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Locally Advanced Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
A Phase 2a Randomized, Parallel Group, Open Label, Multicenter Study to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Locally Advanced Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
Enrollment Status: Completed
Publish Date: November 04, 2024
Intervention Type: Drug, Radiation
Study Phase: Phase 2
View 4 Less Clinical Trials

192 Total Publications

Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck Cancer.
Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 22, 2025
Similar Doctors
Distinguished in Ewing Sarcoma
Dr. Neil N. Senzer
Radiation Oncology
Distinguished in Ewing Sarcoma
Dr. Neil N. Senzer
Radiation Oncology
3410 Worth St, Department Of Radiation Oncology, 
Dallas, TX 
 (3.7 mi)
214-370-1400
Languages Spoken:
English

Neil Senzer is a Radiation Oncologist in Dallas, Texas. Dr. Senzer and is rated as an Advanced provider by MediFind in the treatment of Ewing Sarcoma. His top areas of expertise are Ewing Sarcoma, Osteosarcoma, Melanoma, and Pancreatic Cancer.

Experienced in Ewing Sarcoma
Dr. Nina N. Sanford
Radiation Oncology
Experienced in Ewing Sarcoma
Dr. Nina N. Sanford
Radiation Oncology

University Of Texas Southwestern Medical Center At Dallas

2280 Inwood Rd, 
Dallas, TX 
 (0.5 mi)
214-645-8525
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Nina Sanford is a Radiation Oncologist in Dallas, Texas. Dr. Sanford and is rated as an Advanced provider by MediFind in the treatment of Ewing Sarcoma. Her top areas of expertise are Anal Cancer, Ewing Sarcoma, Gastroesophageal Junction Cancer, Colonoscopy, and Endoscopy.

Experienced in Ewing Sarcoma
Dr. Dominic H. Moon
Radiation Oncology
Experienced in Ewing Sarcoma
Dr. Dominic H. Moon
Radiation Oncology

University Of Texas Southwestern Medical Center At Dallas

2280 Inwood Rd, 
Dallas, TX 
 (0.5 mi)
214-645-8525
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Dominic Moon is a Radiation Oncologist in Dallas, Texas. Dr. Moon and is rated as an Advanced provider by MediFind in the treatment of Ewing Sarcoma. His top areas of expertise are Throat Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Laryngeal Cancer, Lacrimal Gland Tumor, and Prostatectomy.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile